Medicago in vaccine MOU in Japan

Medicago (TSX-V: MDG) has signed a memorandum of understanding with Japan’s NITT Partners to discuss and negotiate an agreement to commercialize Medicago’s pandemic and seasonal influenza VLP-based vaccines in Japan and other territories. For several years, NITT Partners has been the government-approved technology transfer/licensing organization to license-in state of the art technologies. Under the terms [...]